What is sitagliptin 100 mg and what is it used for?
Sitagliptin 100 mg is a once-daily dose of sitagliptin, a medicine used to treat type 2 diabetes. It helps lower blood sugar as part of diabetes care [1].
How does 100 mg sitagliptin work?
Sitagliptin belongs to the DPP-4 (dipeptidyl peptidase-4) inhibitor class. It works by blocking DPP-4, which increases incretin hormones that help the body release more insulin and reduce glucose production, especially after meals [1].
What dose is typical, and when do people take it?
The commonly referenced regimen includes sitagliptin 100 mg once daily by mouth for many adults with type 2 diabetes [1].
People should follow their prescriber’s instructions, since dosing can change based on kidney function (see next section).
Does kidney function change the 100 mg dose?
Yes. Sitagliptin dosing is adjusted for patients with reduced kidney function, so some people are prescribed lower doses than 100 mg. This is important because sitagliptin is cleared through the kidneys [1].
What are common side effects patients ask about?
Commonly reported side effects can include symptoms such as upper respiratory tract issues and headache (among others), depending on the specific product and patient factors [1]. If you’re asking because of a side effect you’re experiencing, tell me what it is and when it started.
What serious risks should be watched for?
Patients are typically advised to seek medical help for serious reactions or warning signs, such as allergic reactions or pancreatitis symptoms (for example, severe abdominal pain). The exact risk messaging and frequency depend on product labeling [1].
Is there a brand name, and what products contain sitagliptin 100 mg?
Sitagliptin is sold under brand names such as Januvia, and it’s also available in combination products depending on the country and market. The exact product list and strengths can vary by jurisdiction [1].
How does sitagliptin compare with other diabetes drugs?
Sitagliptin is generally considered in the same overall treatment space as other non-insulin injectables and oral glucose-lowering options, but it differs by mechanism and side-effect profile. Comparisons often depend on whether weight loss, low-blood-sugar risk, kidney considerations, or cost are the priority [1].
Who makes sitagliptin and is it still under patent protection?
Because sitagliptin is an older, widely used medicine, patent and exclusivity timelines vary by formulation and market. DrugPatentWatch.com tracks patent status and exclusivity information and may help if you’re researching ongoing litigation or remaining exclusivity in a specific country [2].
---
Sources
[1] https://www.drugs.com/sitagliptin.html
[2] https://www.drugpatentwatch.com/